Paper177207
Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.
Graff JC and 1 other. Cancer Res, 1976. Cited by 49 papers, by iCite.
Cite this record
ConductScience Library. Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate. Papers, record 177207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/177207
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Monophosphate | Major topic |
| Alanine | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Inosine Nucleotides | Major topic |
| Liver Neoplasms | Major topic |
| Nitroso Compounds | Major topic |
| Adenine | |
| Adenosine Triphosphate | |
| Aspartic Acid | |
| Cell Division | |
| Cell Line | |
| Cells, Cultured | |
| DNA, Neoplasm | |
| Depression, Chemical | |
| Glucose | |
| Hypoxanthines | |
| Mengovirus | |
| Neoplasm Proteins | |
| Neoplasms, Experimental | |
| Purine Nucleotides | |
| Pyrimidine Nucleotides | |
| RNA, Neoplasm | |
| Succinates | |
| Uracil Nucleotides | |
| Uridine |
Source PubMed
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6678874 | The treatment of acute leukemia with continuous infusion L-Alanosine. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678874 | PubMed |
| 3965163 | Contragestational profile of the tumor-inhibiting agent, L-alanosine, in the rat and the hamster. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3965163 | PubMed |
| 3170135 | Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma. | Invest New Drugs | 1988 | https://conductscience.org/library/papers/3170135 | PubMed |
| 1850608 | Dimethylthiourea inhibition of B16 melanoma growth and induction of phenotypic alterations; relationship to ATP levels. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1850608 | PubMed |
| 568178 | Properties of the thymidine transport system of Chinese hamster ovary cells as probed by nitrobenzylthioinosine. | J Membr Biol | 1978 | https://conductscience.org/library/papers/568178 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/177207
GET https://conductscience.org/api/papers/v1/177207/authors